Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2015, Article ID 240750, 9 pages
http://dx.doi.org/10.1155/2015/240750
Clinical Study

Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

1Analysis Group, Inc., Boston, MA 02199, USA
2Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA
3Analysis Group, Inc., New York, NY 10020, USA

Received 19 February 2015; Revised 23 April 2015; Accepted 24 April 2015

Academic Editor: Zsuzsanna Kahán

Copyright © 2015 Nanxin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nanxin Li, Yanni Hao, Jipan Xie, et al., “Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study,” International Journal of Breast Cancer, vol. 2015, Article ID 240750, 9 pages, 2015. https://doi.org/10.1155/2015/240750.